Tong Su

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 4

Top Topics

Epithelial Mesenchymal Transition

Endometrial Cancer

Signaling Pathway

Top Venues

Cancer immunology research

OncoTargets and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Qiaoying Lv, Tong Su, Wei Liu, Lulu Wang, Jiali Hu, Yali Cheng, Chengcheng Ning, Wei-Wei Shan, Xuezhen Luo, Xiao-Jun Chen
Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α-Glycolysis Pathway. Cancer immunology research 12 (8) (2024)
Qiaoying Lv, Tong Su, Wei Liu, Lulu Wang, Jiali Hu, Yali Cheng, Chengcheng Ning, Wei-Wei Shan, Xuezhen Luo, Xiao-Jun Chen
Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α-Glycolysis Pathway. Cancer immunology research 12 (8) (2024)
Qiaoying Lv, Tong Su, Wei Liu, Lulu Wang, Jiali Hu, Yali Cheng, Chengcheng Ning, Wei-Wei Shan, Xuezhen Luo, Xiao-Jun Chen
Low serum apolipoprotein A1 impairs antitumor immunity of CD8+ T cells via the HIF-1α-glycolysis pathway. Cancer immunology research (2024)
Yihan Bai, Kemin Yin, Tong Su, Fang Ji, Shu Zhang
CTHRC1 in Ovarian Cancer Promotes M2-Like Polarization of Tumor-Associated Macrophages via Regulation of the STAT6 Signaling Pathway. OncoTargets and therapy 13 (2020)